RecruitingNCT07070362

Digital Early Warning System for Acute Lung Injury in Liver Surgery

The Construction of a Digital Intelligence Early Warning System for the Whole Process of Acute Lung Injury in Liver Surgery Based on Cardiopulmonary Interaction Characteristics

Sponsor

Beijing Tsinghua Chang Gung Hospital

Enrollment

3,000 participants

Start Date

Nov 1, 2024

Study Type

OBSERVATIONAL

Conditions

MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Acute Lung Injury(ALI)Liver Cirrhosis ARDS, Human MASLD NAFLD (Nonalcoholic Fatty Liver Disease)Liver Cancer, Adult

Summary

This study aims to develop an explainable machine learning model that takes into account the characteristics of cardiopulmonary interactions. This model will enable early prediction of acute lung injury (ALI) in patients undergoing major liver surgery. The research will create a digital early-warning system for ALI, thereby supporting clinical diagnosis and treatment decisions. This, in turn, should help reduce the incidence and mortality rates associated with ALI.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study develops and tests a digital early warning system to detect acute lung injury in patients who have undergone major liver surgery. The goal is to identify patients at risk earlier so doctors can intervene before the condition becomes serious. **You may be eligible if...** - You are 18 or older - You are scheduled for major liver surgery (removal of two or more liver segments, or a liver transplant) - You agree to participate and sign consent forms **You may NOT be eligible if...** - You are under 18 - You are not scheduled for a qualifying liver procedure - You are unable or unwilling to provide informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(4)

Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine，Tsinghua University

Beijing, Beijing Municipality, China

Peking University International Hospital

Beijing, China

Southwest Hospital, The First Affiliated Hospital of Army Medical University

Chongqing, China

Huangdao District People's Hospital of Qingdao

Qingdao, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07070362

Related Trials

Effect of Handgrip Strength on Portal Vein Hemodynamics in Patients With Liver Cirrhosis

NCT071160962 locations

Using Autologous Bone Marrow Cells With Wharton Gel Exosomes to Stimulate Hepatic Cell Repair in Liver Cirrhosis

NCT07374185

A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).

NCT058951369 locations

Effect of Laparoscopic Hepatectomy Combined With Splenectomy on Hepatic Functional Reserve and Immune Function

NCT07811687

GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC

NCT048640548 locations